Filing Details

Accession Number:
0001178913-14-001187
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-04-02 13:59:19
Reporting Period:
2014-03-31
Filing Date:
2014-04-02
Accepted Time:
2014-04-02 13:59:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1176309 Oramed Pharmaceuticals Inc. ORMP Pharmaceutical Preparations (2834) 980376008
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1493383 Michael Berelowitz 415 East 37Th Street
New York NY 10016
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-03-31 3,334 $4.08 3,334 No 4 M Direct
Common Stock Acquisiton 2014-03-31 6,100 $5.76 9,434 No 4 M Direct
Common Stock Disposition 2014-03-31 9,434 $10.50 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2014-03-31 3,334 $0.00 3,334 $4.08
Common Stock Stock Option (right to buy) Disposition 2014-03-31 6,100 $0.00 6,100 $5.76
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2022-08-08 No 4 M Direct
18,900 2020-07-07 No 4 M Direct
Footnotes
  1. The number of shares underlying such Stock Options and the applicable exercise price reflect a one-for-twelve reverse stock split effected by the issuer on January 22, 2013.
  2. This Stock Option vested in equal parts on each of January 1, 2013 and January 1, 2014.
  3. This Stock Option vested in equal parts on each of July 8, 2011, July 8, 2012 and July 8, 2013.